<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31709624</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4644</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of cellular biochemistry</Title><ISOAbbreviation>J Cell Biochem</ISOAbbreviation></Journal><ArticleTitle>The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways.</ArticleTitle><Pagination><StartPage>934</StartPage><EndPage>944</EndPage><MedlinePgn>934-944</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jcb.29533</ELocationID><Abstract><AbstractText>Pancreatic cancer is always diagnosed at an advanced stage. Hence, chemotherapy becomes the best choice for patients. Therefore, new anticancer drugs for pancreatic cancer are needed. Riluzole (RIL) is mainly used to treat amyotrophic lateral sclerosis clinically, but many previous studies have shown that RIL could inhibit tumors. However, no report has explored the association between RIL and pancreatic cancer. To validate this association, we performed this study. Our data showed that RIL could induce cytotoxicity, block the cell cycle, and inhibit clone formation, apoptosis, and migration in pancreatic cancer cells. Moreover, we demonstrated that RIL could suppress autophagy. However, more experiments will be needed to validate the reliability of our conclusions. In summary, our data suggest that RIL might provide clues for the development of a treatment for human pancreatic cancer in the future.</AbstractText><CopyrightInformation>&#xa9; 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rulin</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8525-8929</Identifier><AffiliationInfo><Affiliation>Clinical Laboratory&#xa0;Center, Zhejiang Provincial People's Hospital, Zhejiang, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>People's Hospital of Hangzhou Medical College, Hangzhou, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Zhejiang, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, Zhejiang, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xujun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>People's Hospital of Hangzhou Medical College, Hangzhou, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, Zhejiang, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xiaoting</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Laboratory&#xa0;Center, Zhejiang Provincial People's Hospital, Zhejiang, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>People's Hospital of Hangzhou Medical College, Hangzhou, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, Zhejiang, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Houquan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>People's Hospital of Hangzhou Medical College, Hangzhou, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, Zhejiang, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>C, Foundation of Zhejiang Provincial Health Bureau (N), National Natural Science Foundation of China (81803087) Natural Science Foundation of Zhejiang Province, Outstanding Young Personnel Research Fund of Zheji</GrantID><Agency>Rulin Sun</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cell Biochem</MedlineTA><NlmUniqueID>8205768</NlmUniqueID><ISSNLinking>0730-2312</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7LJ087RS6F</RegistryNumber><NameOfSubstance UI="D019782">Riluzole</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C562463">Pancreatic Carcinoma</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019782" MajorTopicYN="N">Riluzole</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="Y">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">chemotherapy</Keyword><Keyword MajorTopicYN="N">pancreatic cancer</Keyword><Keyword MajorTopicYN="N">riluzole</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31709624</ArticleId><ArticleId IdType="doi">10.1002/jcb.29533</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Siegel RL , Miller KD , Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. https://doi.org/10.3322/caac.21442</Citation></Reference><Reference><Citation>Kindler HL . A glimmer of hope for pancreatic cancer. N Engl J Med. 2018;379(25):2463-2464. https://doi.org/10.1056/NEJMe1813684</Citation></Reference><Reference><Citation>Reiter JG , Iacobuzio-Donahue CA . Pancreatic cancer: pancreatic carcinogenesis - several small steps or one giant leap? Nat Rev Gastroenterol Hepatol. 2016;14(1):7-8. https://doi.org/10.1038/nrgastro.2016.190</Citation></Reference><Reference><Citation>Vakoc CR , Tuveson DA . Soils and seeds that initiate pancreatic cancer metastasis. Cancer Discov. 2017;7(10):1067-1068. https://doi.org/10.1158/2159-8290.CD-17-0887</Citation></Reference><Reference><Citation>Lin QJ , Yang F , Jin C , Fu DL . Current status and progress of pancreatic cancer in China. World J Gastroenterol. 2015;21(26):7988-8003. https://doi.org/10.3748/wjg.v21.i26.7988</Citation></Reference><Reference><Citation>Hackeng WM , Hruban RH , Offerhaus GJ , Brosens LA . Surgical and molecular pathology of pancreatic neoplasms. Diagn Pathol. 2016;11(1):47. https://doi.org/10.1186/s13000-016-0497-z</Citation></Reference><Reference><Citation>Zhang D , Wu J , Liu S , Zhang X , Zhang B . Network meta-analysis of Chinese herbal injections combined with the chemotherapy for the treatment of pancreatic cancer. Medicine (Baltimore). 2017;96(21):e7005. https://doi.org/10.1097/MD.0000000000007005</Citation></Reference><Reference><Citation>Chen R , Lai LA , Sullivan Y , et al. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Sci Rep. 2017;7(1):7950. https://doi.org/10.1038/s41598-017-08436-6</Citation></Reference><Reference><Citation>Jaiswal MK . Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med Res Rev. 2019;39(2):733-748. https://doi.org/10.1002/med.21528</Citation></Reference><Reference><Citation>Seol HS , Lee SE , Song JS , et al. Glutamate release inhibitor, riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production. Cancer Lett. 2016;382(2):157-165. https://doi.org/10.1016/j.canlet.2016.08.028</Citation></Reference><Reference><Citation>Zhang C , Yuan XR , Li HY , et al. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway. Cell Physiol Biochem. 2015;35(2):419-432. https://doi.org/10.1159/000369707</Citation></Reference><Reference><Citation>Ou L , Lin S , Song B , Liu J , Lai R , Shao L . The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis. Int J Nanomedicine. 2017;12:6633-6646. https://doi.org/10.2147/IJN.S140526</Citation></Reference><Reference><Citation>Neves SP , de Carvalho NC , da Silva MM , et al. Ruthenium complexes containing heterocyclic thioamidates trigger caspase-mediated apoptosis through MAPK signaling in human hepatocellular carcinoma cells. Front Oncol. 2019;9:562. https://doi.org/10.3389/fonc.2019.00562</Citation></Reference><Reference><Citation>Milani R , Brognara E , Fabbri E , et al. Targeting miR1555p and miR2213p by peptide nucleic acids induces caspase3 activation and apoptosis in temozolomide resistant T98G glioma cells. Int J Oncol. 2019;55(1):59-68. https://doi.org/10.3892/ijo.2019.4810</Citation></Reference><Reference><Citation>Lorente J , Velandia C , Leal JA , et al. The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapy. Biol Rev Camb Philos Soc. 2018;93(1):152-165. https://doi.org/10.1111/brv.12337</Citation></Reference><Reference><Citation>Yang A , Herter-Sprie G , Zhang H , et al. Autophagy sustains pancreatic cancer growth through both cell-autonomous and nonautonomous mechanisms. Cancer Discov. 2018;8(3):276-287. https://doi.org/10.1158/2159-8290.CD-17-0952</Citation></Reference><Reference><Citation>Goral V . Pancreatic cancer: pathogenesis and diagnosis. Asian Pac J Cancer Prev. 2015;16(14):5619-5624.</Citation></Reference><Reference><Citation>Ahmad A , Khan F , Mishra RK , Khan R . Precision cancer nanotherapy: evolving role of multifunctional nanoparticles for cancer active targeting. J Med Chem. 2019. https://doi.org/10.1021/acs.jmedchem.9b00511</Citation></Reference><Reference><Citation>Fahmy SA , Brussler J , Alawak M , El-Sayed MMH , Bakowsky U , Shoeib T . Chemotherapy based on supramolecular chemistry: a promising strategy in cancer therapy. Pharmaceutics. 2019;11(6):E292. https://doi.org/10.3390/pharmaceutics11060292</Citation></Reference><Reference><Citation>Satkunendrarajah K , Nassiri F , Karadimas SK , Lip A , Yao G , Fehlings MG . Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection. Exp Neurol. 2016;276:59-71. https://doi.org/10.1016/j.expneurol.2015.09.011</Citation></Reference><Reference><Citation>Wen Y , Li J , Koo J , et al. Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression. Cancer Res. 2014;74(9):2499-2509. https://doi.org/10.1158/0008-5472.CAN-13-1531</Citation></Reference><Reference><Citation>Yu LJ , Wall BA , Wangari-Talbot J , Chen S . Metabotropic glutamate receptors in cancer. Neuropharmacology. 2017;115:193-202. https://doi.org/10.1016/j.neuropharm.2016.02.011</Citation></Reference><Reference><Citation>Martino JJ , Wall BA , Mastrantoni E , et al. Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells. Oncogene. 2013;32(37):4366-4376. https://doi.org/10.1038/onc.2012.471</Citation></Reference><Reference><Citation>Lv C , Yuan X , Zeng HW , Liu RH , Zhang WD . Protective effect of cinnamaldehyde against glutamate-induced oxidative stress and apoptosis in PC12 cells. Eur J Pharmacol. 2017;815:487-494. https://doi.org/10.1016/j.ejphar.2017.09.009</Citation></Reference><Reference><Citation>Lemieszek MK , Stepulak A , Sawa-Wejksza K , Czerwonka A , Ikonomidou C , Rzeski W . Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins. Anticancer Agents Med Chem. 2018;18(4):565-572. https://doi.org/10.2174/1871520618666180228152713</Citation></Reference><Reference><Citation>Tait SW , Ichim G , Green DR . Die another way--non-apoptotic mechanisms of cell death. J Cell Sci. 2014;127(Pt 10):2135-2144. https://doi.org/10.1242/jcs.093575</Citation></Reference><Reference><Citation>Jiang TX , Zou JB , Zhu QQ , et al. SIP/CacyBP promotes autophagy by regulating levels of BRUCE/Apollon, which stimulates LC3-I degradation. Proc Natl Acad Sci USA. 2019;116(27):13404-13413. https://doi.org/10.1073/pnas.1901039116</Citation></Reference><Reference><Citation>Luhr M , Torgersen ML , Szalai P , et al. The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress. J Biol Chem. 2019. https://doi.org/10.1074/jbc.RA118.002829</Citation></Reference><Reference><Citation>Bryant KL , Der CJ . Blocking autophagy to starve pancreatic cancer. Nat Rev Mol Cell Biol. 2019;20(5):265. https://doi.org/10.1038/s41580-019-0120-8</Citation></Reference><Reference><Citation>Fu ZP , Cheng X , Kuang J , et al. CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species. Mol Oncol. 2018;12(4):529-544. https://doi.org/10.1002/1878-0261.12179</Citation></Reference><Reference><Citation>Zhang YB , Gong JL , Xing TY , Zheng SP , Ding W . Autophagy protein p62/SQSTM1 is involved in HAMLET-induced cell death by modulating apotosis in U87MG cells. Cell Death Dis. 2013;4:e550. https://doi.org/10.1038/cddis.2013.77</Citation></Reference><Reference><Citation>Marino G , Niso-Santano M , Baehrecke EH , Kroemer G . Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15(2):81-94. https://doi.org/10.1038/nrm3735</Citation></Reference><Reference><Citation>Xue R , Yang J , Jia L , et al. Mitofusin2, as a protective target in the liver, controls the balance of apoptosis, and autophagy in acute-on-chronic liver failure. Front Pharmacol. 2019;10:601. https://doi.org/10.3389/fphar.2019.00601</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>